DanCann Pharma A/S: Chairman of the board and management subscribes for units in the ongoing IPO
DENMARK, October 9, 2020 – DanCann Pharma A/S (” DanCann Pharma” or the “Company”) is currently carrying out a new issue of units prior to the listing of the Company's shares and warrants on the Spotlight Stock Market. As previously communicated in the prospectus, the board members Per Wester and Carsten Trads have announced that they have undertaken subscription commitment agreements for units in the new issue. DanCann Pharma’s Chairman of the Board, Magnus Østergaard Dahlmann, Chief Commercial Officer, John Morell Frellsen (who works for the Company as a consultant and is thereby not part